You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Novo Nordisk Articles
Popular Novo Nordisk Articles
Highly Recommended Novo Nordisk Articles
Send a link to this page to your friends and colleagues.
On April 27, three days after glargine (Lantus) was approved by the U.S. Food and Drug Administration, Novo Nordisk filed a lawsuit with the Court of Dusseldorf in Germany against Aventis for patent infringement.
Novo claims that the production and sale of the 24-hour basal insulin infringes two German patents held by Novo Nordisk.
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.